Histone H3K27M mutation overrides histological grading in pediatric gliomas A Mosaab, M El-Ayadi, EN Khorshed, N Amer, A Refaat, M El-Beltagy, ... Scientific reports 10 (1), 8368, 2020 | 63 | 2020 |
Cancer pathology registry 2000-2011 N Mokhtar, A Salama, O Badawy, E Khorshed, G Mohamed, M Ibrahim, ... Cairo, Egypt: National Cancer Institute Cairo University. Back to cited text 18, 2016 | 27 | 2016 |
Cancer Pathology Registry A 12-year Registry 2000–2011 N Mokhtar, A Salama, O Badawy, E Khorshed, G Mohamed, M Ibrahim, ... National Cancer Institute 13, 192-208, 2016 | 22 | 2016 |
A case of STK4 deficiency with complications evoking mycobacterial infection N Radwan, R El-Owaidy, ZA El-Sayed, A Abdel-Baky, A El-Haddad, ... Journal of Clinical Immunology 40, 665-669, 2020 | 10 | 2020 |
C-MYC protein expression and high ki-67 proliferative index are predictives of disease relapse in diffuse large b cell lymphoma MT El-Hussien, N Mokhtar, EN Khorshed Asian Pacific Journal of Cancer Biology 6 (1), 15-20, 2021 | 4 | 2021 |
Immunohistochemical Expression of p27 in Ductal Carcinoma of Breast and its Correlation with HER2/neu Expression and Hormonal Status EK Yehia Mohammed Fayed, Samar Abdel-Monem El-Sheikh, Iman Loay Egyptian Journal of Pathology. 32(1); 33-41., 33-41, 2012 | 4* | 2012 |
Prognostic significance of survivin expression in pediatric ewing sarcoma AM Mahmoud, W Zekri, EN Khorshed, LM Shalaby Pediatric Hematology and Oncology 39 (1), 16-27, 2022 | 3 | 2022 |
Prognostic Values of MicroRNA-21 and Ki-67 in Diffuse Large B-Cell Lymphoma Patients: Egyptian Experience. HA Asker, EN Khorshed, MR Ahmed, LA Refaat, HM Khaled, RA Rashed Clinical Laboratory, 2021 | 2 | 2021 |
Significance of ERCC1 and Hormonal Receptor Expression in Ovarian Cancer DAE Elrawi, HR Nassar, AD Darwish, EN Khorshed The Journal of Medical Investigation 67 (3.4), 391-398, 2020 | 2 | 2020 |
Variant histology of pediatric nodular lymphocyte‐predominant Hodgkin lymphoma with IgD and CD30 expression N Ali, E Moussa, E Khorshed, MS Zaghloul, A Elnashar, A Abdalla Pediatric Blood & Cancer 70 (11), e30647, 2023 | 1 | 2023 |
Outcome and toxicity of ifosfamide, carboplatin, and etoposide versus gemcitabine and vinorelbine regimen for pediatric patients with relapsed or refractory Hodgkin’s lymphoma A Mahdy, A Hamoda, A Zaher, E Khorshed, M Elwakeel, O Hassanein, ... Frontiers in Oncology 13, 1153128, 2023 | 1 | 2023 |
Clinical correlation between Programmed Cell Death Ligand One (PD L-1) Expression, Tumor Infiltrating Lymphocytes (TILs) and pathological response of locally advanced Human … E Shash, E Khorshed, A Namour, E El Desouky, A Bahnassy, ... European Journal of Cancer 138, S73, 2020 | 1 | 2020 |
Pediatric Infradiaphragmatic Hodgkin’s lymphoma: a unique identity N Ezzeldeen, E Moussa, M El Wakeel, M Mehesen, E Khorshed, ... Annals of Lymphoma 8, 2024 | | 2024 |
High-grade glioma in infants and very young children: characteristics, treatment, and outcomes O Arafah, E Maher, A Mosaab, E Naguib, A Mohamed, S Ahmed, H Taha, ... | | 2023 |
ABCL-262 Diffuse Large B Cell Lymphoma in a Child With Epidermodysplasia Verruciformis, Case Report A Elgammal, EN Khorshed Clinical Lymphoma Myeloma and Leukemia 23, S427, 2023 | | 2023 |
PB2254: TREATMENT OUTCOME AND PROGNOSTIC FACTORS IN CHILDREN AND ADOLESCENTS WITH RELAPSED AND REFRACTORY CLASSIC HODGKIN LYMPHOMA N Ali, E Moussa, HA Rahman, H Hafez, MS Zaghloul, E Khorshed, ... HemaSphere 7 (S3), e780924d, 2023 | | 2023 |
INFRADIAPHRAGMATIC HODGKIN'S LYMPHOMA IN PEDIATRIC CANCER PATIENTS NE Eldeen, E Moussa, MS Zaghloul, M Elwakeel, E Khorshed, M Omran, ... PEDIATRIC BLOOD & CANCER 69, S197-S198, 2022 | | 2022 |
GEMCITABINE AND VINORELBINE (GV) VERSUS IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE (ICE) REGIMEN IN TREATING PEDIATRIC PATIENTS WITH RECURRENT OR PROGRESSIVE HODGKIN'S LYMPHOMA A Mahdy, A Hamoda, A Zaher, E Khorshed, M Elwakeel, O Hassanein, ... PEDIATRIC BLOOD & CANCER 69, S204-S204, 2022 | | 2022 |
PROGNOSTIC SIGNIFICANCE OF PD1, PD-L1 EXPRESSION AND METABOLIC ACTIVITY ON 18F-FDG PET/CT IN REFRACTORY/RELAPSING PEDIATRIC HODGKIN LYMPHOMA R Khedr, E Khorshed, H Abdelrahman, O Hassanein, M Elwakeel, ... PEDIATRIC BLOOD & CANCER 69, S198-S199, 2022 | | 2022 |
PROGNOSTIC SIGNIFICANCE OF PD1, PD-L1 EXPRESSION, PATHOLOGICAL SUBTYPES AND METABOLIC ACTIVITY ON 18F-FDG PET/CT IN REFRACTORY/RELAPSING PEDIATRIC HODGKIN LYMPHOMA R Khedr, E Khorshed, O Hassanain, H Rahman, M Elwakil, M Zaghloul, ... Leukemia Research 121, S61, 2022 | | 2022 |